Article
Biomarker driven drug repurposing for Fuchs’ Endothelial Corneal Dystrophy (FECD): A Computational study
2024-08-26
Abstract excerpt
<title>Abstract</title> <p>Fuchs’ Endothelial Corneal Dystrophy (FECD) is a slowly advancing, non-inflammatory eye condition due to gradual increase in thickness of the Descemet’s membrane and the gradual decline in corneal endothelial cells population. It can occur sporadically or be inherited in an autosomal dominant manner leading to impaired vision over time. The only available method to treat FECD is corneal...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f7298285-30c5-56f2-bead-a825e4dc64ee
- DOI
- 10.21203/rs.3.rs-4820986/v1
